Metabolic Syndrome (Underlying Mechanisms and Drug Therapies) || Sodium Glucose Cotransporter 2 Inhibitors
- 作者Wang, Minghan
- 文件大小277.97KB
- 发表时间2011
- DOI10.1002/9780470910016.ch13
- 页码359-375
Metabolic Syndrome (Underlying Mechanisms and Drug Therapies) || Mechanisms and Complications of Metabolic SyndromeWang, Minghan · 2011
Metabolic Syndrome (Underlying Mechanisms and Drug Therapies) ||Wang, Minghan · 2011
Metabolic Syndrome (Underlying Mechanisms and Drug Therapies) || FrontmatterWang, Minghan · 2011
Metabolic Syndrome (Underlying Mechanisms and Drug Therapies) || IndexWang, Minghan · 2011
Metabolic Syndrome (Underlying Mechanisms and Drug Therapies) || Sirtuins as Potential Drug Targets for Metabolic DiseasesWang, Minghan · 2011
Metabolic Syndrome (Underlying Mechanisms and Drug Therapies) || Current Antidiabetic Therapies and MechanismsWang, Minghan · 2011
Metabolic Syndrome (Underlying Mechanisms and Drug Therapies) || Drug Development for Metabolic Diseases: Past, Present and FutureWang, Minghan · 2011
Small Molecule 11β- Hydroxysteroid Dehydrogenase Type 1 InhibitorsSun, Daqing; Wang, Minghan; Wang, Zhulun · Current Topics in Medicinal Chemistry · 2011
Fluid dynamics of a novel reactive distillation reactorMinghan Han; Hongfei Lin; Jinfu Wang; Dezheng Wang; Yong Jin · 2004
Metabolic Syndrome (Underlying Mechanisms and Drug Therapies) ||Wang, Minghan · 2011
Structure and Inhibitor Binding Mechanisms of 11β -Hydroxysteroid Dehydrogenase Type 1Wang, Zhulun; Wang, Minghan · Current Chemical Biology · 2009
HDL: The Metabolism, Function, and Therapeutic ImportanceMinghan Wang; Michael R. Briggs · 2004
A note on cubic polynomial interpolationMinghan Hu; Xiquan Shi; Tianjun Wang; Fengshan Liu · 2008
Chemistry and Biochemistry of Type 2 DiabetesStuart A. Ross; Eric A. Gulve; Minghan Wang · 2004
Chemistry and Biochemistry of Type 2 DiabetesRoss, Stuart A.; Gulve, Eric A.; Wang, Minghan · 2004